A trio of studies help mark the end of the PHE, and recap some of the health policy lessons learned from this unprecedented period.
Health Law
Posted inHealth Law
A Closer Look at the Abortion Medication Mifepristone
What is the abortion drug at the center of a new legal maelstrom–and what happens if patients lose access to it?
Posted inInsurance
The Latest Threat to the Affordable Care Act
ACA expert Nicholas Bagley breaks down the court ruling striking down the popular requirement for insurers to offer free preventive care services.
Posted inHealth Law
The Conservative Clash Over Abortion Bans
Republican lawmakers in at least seven states are pushing to make their state abortion bans less restrictive.
Posted inInsurance
SCOTUS Weighs Medicaid Recipients’ Right to Sue
A Supreme Court case could change whether Medicaid recipients can continue to use a legal pathway to enforce their rights.
Posted inPublic Health
Three Health Policy Stories to Watch in 2023
In 2023, states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare will begin to flex its new power to negotiate drug prices.
Posted inHealth Equity
Breaking Down Biden’s New Nondiscrimination Rule
Katie Keith shares about a newly proposed rule to Section 1557, a civil rights pillar of the Affordable Care Act.
Posted inHealth Law
What Research Says About a Post-Roe World
The leader of a landmark abortion study shares what research and her own family experience suggest will happen to people who are denied abortions.
Posted inHealth Law
Four Studies to Help You Make Sense of a Post-Roe World
This week our Research Council shares studies to help make sense of a Post-Roe world.
Posted inHealth Law
The Personal and Political Fight to Keep Abortion Legal in Michigan
How one woman’s personal experience with an illegal abortion is driving her to keep the procedure legal in Michigan.